Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Clinical trial NCT06712316 · RECRUITING

Trial details

NCT number: NCT06712316
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2025-01-07
Primary completion: 2029-01-01
Enrollment: 1580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.